SCHEMBL20733792

SCHEMBL20733792

c1ccc(-c2nnc3c4nnc(-c5ccccc5)nc4c4nc(-c5ccccc5)nnc4c3n2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.62
▸ NPC1 O15118 3/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ MAPT P10636 3/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ NFKB2 Q00653 2/20 0.47
▸ RELA Q04206 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ KDM4C Q9H3R0 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ LMNA P02545 2/20 0.43
▸ NR1H4 Q96RI1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733812 0.78 AVPR1A (0.44) RAB9ANPC1MAPK1SMN1; SMN2ALDH1A1
SCHEMBL3652642 0.78 NPC1 (1.00) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL20733720 0.78 NPC1 (0.46) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL12761842 0.76 NPC1 (0.45) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL20733715 0.75 NPC1 (0.43) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL17104884 0.74 RAB9A (0.60) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL3445210 0.73 SMN1; SMN2 (0.81) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL2851617 0.73 NPC1 (0.59) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL29887199 0.73 NPC1 (0.59) RAB9ANPC1MAPK1SMN1; SMN2MAPT
SCHEMBL24729180 0.72 RAB9A (0.45) RAB9ANPC1MAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 — — US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 RAB9A 2642/4885NPC1 1206/4885MAPK1 3206/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 RAB9A 2642/4885NPC1 1206/4885MAPK1 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback